XETRA · MRK.DE
Merck KGaA
€150.30+€4.25 (+2.91%)
Merck KGaA’s quoted price sits in the upper half of its reported 52-week range, 0.86% below the high.
Loading market information…
NASDAQ · QUCY · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Quantum Cyber N.V.’s quoted price sits in the lower half of its reported 52-week range, 81.35% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Quantum Cyber N.V.’s next earnings report is currently expected on Nov 13, 2026, with estimated earnings per share of -$0.08. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Quantum Cyber N.V.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions. The company pursues acquisitions and partnerships in areas including post-quantum cryptography, zero-trust architecture, and national security technologies. It also develops platforms that integrate artificial intelligence (AI) and quantum computing technologies for autonomous control systems used in unmanned aerial, ground, and underwater vehicles, including drones, self-driving vehicles, and robotic fleets. Quantum Cyber N.V. was formerly known as Mainz Biomed N.V. and changed its name to Quantum Cyber N.V. in April 2026. The company is headquartered in Mainz, Germany.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:17 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q3 2024 | May 16, 2023 | -$18.00+8.16% vs estimate | $250.08K-6.22% vs estimate |
|---|
| Q2 2024 | Sep 7, 2022 | -$36.40 | $239.81K |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
€150.30+€4.25 (+2.91%)
Merck KGaA’s quoted price sits in the upper half of its reported 52-week range, 0.86% below the high.
€42.89+€0.30 (+0.7%)
Siemens Healthineers AG’s quoted price sits in the upper half of its reported 52-week range, 13.7% below the high.
€47.96+€1.93 (+4.19%)
Bayer Aktiengesellschaft’s quoted price sits in the upper half of its reported 52-week range, 11.05% below the high.
MX$953.08MX$0.00 (0.0%)
Bayer AG’s quoted price sits in the upper half of its reported 52-week range, 5.56% below the high.
€47.00+€0.67 (+1.44%)
Fresenius SE & Co. KGaA’s quoted price sits in the upper half of its reported 52-week range, 11.25% below the high.
€77.90+€0.45 (+0.58%)
BioNTech SE’s quoted price sits in the lower half of its reported 52-week range, 26.3% below the high.
€298.50+€6.00 (+2.05%)
Sartorius AG’s quoted price sits in the upper half of its reported 52-week range, 0.27% below the high.
€41.47+€0.87 (+2.14%)
Fresenius Medical Care AG & Co. KGaA’s quoted price sits in the upper half of its reported 52-week range, 12.77% below the high.
